QA: Intra Cellular Therapies Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001567514_2025_Intra_Cellular_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001567514, Intra Cellular Therapies Inc

  xvar xval
0 AssetsCurrent 1,307,364,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,468,000
3 remainder_Assets 58,080,000
4 LiabilitiesCurrent 205,704,000
5 LiabilitiesNoncurrent 12,748,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 901,798,358
9 ResearchAndDevelopmentExpense 251,659,907
10 remainder_Expenses 172,668,521
11 remainder_Revenues 1,762,732,435
12 remainder_NetIncome 35,243,734
13 remainder_ComprehensiveNetIncome 2,132,064
  yvar yval
0 Assets 1,366,912,000
1 Liabilities 218,452,000
2 Expenses 1,326,126,786
3 Revenues 1,762,732,435
4 StockholdersEquity 1,148,460,000
5 NetIncome 471,849,383
6 ComprehensiveNetIncome 472,915,415
7 BaseVar 2,355,799,510
8 EconomicCapitalRatiobeforeLimitedLiability 3.76
9 EconomicCapitalRatio 4.21

Edgar->Model Mapping

Feature Distribution

Change over Time